Oppenheimer Reiterates Outperform Rating on Zentalis Pharmaceuticals (ZNTL)

Go back to Oppenheimer Reiterates Outperform Rating on Zentalis Pharmaceuticals (ZNTL)
(NASDAQ: ZNTL) Delayed: 3.56 --0 (-0%)
Previous Close $3.56    52 Week High
Open $3.56    52 Week Low
Day High $3.56    P/E N/A 
Day Low $3.56    EPS
Volume 5,387